OEDIT Grant Award
We are proud to announce that on Nov 21, 2019, Colorado’s Office of Economic Development & International Trade (OEDIT)’s Advanced Industries Accelerator Program announced that BioLoomics was awarded a $240,000 Early Stage Capital Retention Grant. We are grateful for the support from the State of Colorado, and look forward to growing our company and ultimately creating more Advanced Industry jobs in Colorado.
The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries that drive the State’s economic growth.
View More News
BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs
Former CSO of Trilo Therapeutics and Research Fellow atAbbVie joins to lead BioLoomics’ pipeline and combine lysosome targetingantibodies with ADCs
Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders
BioLoomics’ goal is to make a degrader from an antibody in one month
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Our mission is to make safer, more effective cancer therapeutics.
Pre-Seed Extension
BioLoomics closed a $575,000 round of pre seed extension funding on May 11, 2021..
OEDIT Grant Award
The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries...
BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform
We are excited to announce that on May 30, 2019, BioLoomics closed a $600,000 pre-seed round...
